• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有伏立康唑的人羊膜的药物储存功能:一项研究。

Drug reservoir function of voriconazole impregnated human amniotic membrane: An study.

机构信息

Department of Cornea and Refractive Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Department of Ocular Pharmacology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2021 May;69(5):1068-1072. doi: 10.4103/ijo.IJO_2649_20.

DOI:10.4103/ijo.IJO_2649_20
PMID:33913834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186651/
Abstract

PURPOSE

Earlier our group has demonstrated the drug reservoir function of the human amniotic membrane (HAM) using stable moxifloxacin and fortified cefazolin ophthalmic formulations and found it as a suitable tool to deliver drugs for an extended duration. The purpose of this study was to evaluate the extended-release kinetics of voriconazole from the impregnated human amniotic membrane (HAM) in vitro.

METHODS

HAM buttons were incubated with freshly prepared 1% topical ophthalmic formulation of voriconazole for 5 different exposure time to investigate the ideal exposure time for the extended-release of voriconazole from HAM. The drug release kinetics was studied in simulated tear fluid for 5 weeks and the amount of voriconazole released at different intervals was estimated using high-performance liquid chromatography (HPLC) with photodiode array (PDA) detector.

RESULTS

There was a marginal increase in drug entrapment efficiency with increased drug exposure time but neither the drug entrapment nor the drug release was found to be statistically significant (P ≥ 0.5). Voriconazole was detectable even at 5 weeks.

CONCLUSION

A sustained release of voriconazole was achieved up to 5 weeks, when voriconazole was incubated with amniotic membrane for all the studied drug soaking times. Thus, voriconazole impregnated amniotic membrane can be considered for the sustained delivery for its in fungal keratitis.

摘要

目的

我们的研究小组先前已经证实,使用稳定的莫西沙星和强化头孢唑林眼科制剂的人羊膜(HAM)具有药物储库功能,并发现其是一种可用于延长药物作用时间的合适工具。本研究旨在评估载唑康唑的人羊膜(HAM)在体外的缓释动力学。

方法

将 HAM 纽扣用新制备的 1%局部眼用唑康唑制剂孵育 5 种不同的暴露时间,以研究从 HAM 中延长释放唑康唑的理想暴露时间。在模拟泪液中研究药物释放动力学 5 周,并使用高效液相色谱法(HPLC)和光电二极管阵列(PDA)检测器在不同时间间隔估计释放的唑康唑量。

结果

随着药物暴露时间的增加,药物包封效率略有增加,但药物包封和药物释放均无统计学意义(P≥0.5)。即使在 5 周时也能检测到唑康唑。

结论

当唑康唑与人羊膜孵育所有研究的药物浸泡时间时,可实现长达 5 周的持续释放。因此,载唑康唑的人羊膜可用于真菌性角膜炎的持续释放。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/8186651/6f6ec0774d28/IJO-69-1068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/8186651/6f6ec0774d28/IJO-69-1068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9b6/8186651/6f6ec0774d28/IJO-69-1068-g001.jpg

相似文献

1
Drug reservoir function of voriconazole impregnated human amniotic membrane: An study.载有伏立康唑的人羊膜的药物储存功能:一项研究。
Indian J Ophthalmol. 2021 May;69(5):1068-1072. doi: 10.4103/ijo.IJO_2649_20.
2
In Vitro Evaluation of the Drug Reservoir Function of Human Amniotic Membrane Using Moxifloxacin as a Model Drug.
Cornea. 2017 May;36(5):594-599. doi: 10.1097/ICO.0000000000001168.
3
Human amniotic membrane as a drug carrier - An in-vitro study using fortified cefazolin ophthalmic solution.人羊膜作为药物载体 - 应用强化头孢唑林眼科溶液的体外研究。
Indian J Ophthalmol. 2019 Apr;67(4):472-475. doi: 10.4103/ijo.IJO_1336_18.
4
Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis.
Cornea. 2018 May;37(5):651-654. doi: 10.1097/ICO.0000000000001545.
5
Nanosuspension as an Efficient Carrier for Improved Ocular Permeation of Voriconazole.纳米混悬剂作为一种有效的载体,可提高伏立康唑的眼部渗透。
Curr Pharm Biotechnol. 2021;22(2):245-253. doi: 10.2174/1389201021999200820154918.
6
In situ forming and mucoadhesive ophthalmic voriconazole/HPβCD hydrogels for the treatment of fungal keratitis.原位形成和黏膜黏附性眼科伏立康唑/HPβCD 水凝胶治疗真菌性角膜炎。
Int J Pharm. 2021 Mar 15;597:120318. doi: 10.1016/j.ijpharm.2021.120318. Epub 2021 Feb 1.
7
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.在一项随机试验中对局部用1%伏立康唑和5%那他霉素治疗真菌性角膜炎的重新评估。
Br J Ophthalmol. 2015 Sep;99(9):1190-5. doi: 10.1136/bjophthalmol-2014-306485. Epub 2015 Mar 4.
8
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.伏立康唑与那他霉素治疗真菌性角膜溃疡的对比研究。
Clin Exp Ophthalmol. 2011 Jul;39(5):434-40. doi: 10.1111/j.1442-9071.2010.02473.x. Epub 2011 Jun 28.
9
Topical and oral voriconazole in the treatment of fungal keratitis.局部及口服伏立康唑治疗真菌性角膜炎
Am J Ophthalmol. 2007 Jan;143(1):151-3. doi: 10.1016/j.ajo.2006.07.033. Epub 2006 Aug 31.
10
Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.局部与基质内伏立康唑作为难治性真菌性角膜炎辅助治疗与那他霉素的比较评价。
Ophthalmology. 2013 Apr;120(4):677-81. doi: 10.1016/j.ophtha.2012.09.023. Epub 2012 Dec 12.

引用本文的文献

1
Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine.从再生医学中耦合支架和药物递送系统的角度看待脱细胞羊膜。
J Tissue Eng Regen Med. 2025 Jul 23;2025:8818058. doi: 10.1155/term/8818058. eCollection 2025.
2
Amniotic miracle: Investigating the unique development and applications of amniotic membrane in wound healing.羊膜奇迹:探究羊膜在创伤愈合中的独特发展和应用。
Skin Res Technol. 2024 Jul;30(7):e13860. doi: 10.1111/srt.13860.
3
Safety Considerations for Lyophilized Human Amniotic Membrane Impregnated with Colistin and Silver Nanoparticles.

本文引用的文献

1
Intrastromal voriconazole: An adjuvant approach for recalcitrant mycotic keratitis.基质内伏立康唑:治疗难治性真菌性角膜炎的辅助方法。
Indian J Ophthalmol. 2020 Jan;68(1):35-38. doi: 10.4103/ijo.IJO_378_19.
2
Human amniotic membrane as a drug carrier - An in-vitro study using fortified cefazolin ophthalmic solution.人羊膜作为药物载体 - 应用强化头孢唑林眼科溶液的体外研究。
Indian J Ophthalmol. 2019 Apr;67(4):472-475. doi: 10.4103/ijo.IJO_1336_18.
3
Fungal keratitis: An overview of clinical and laboratory aspects.真菌性角膜炎:临床与实验室方面概述。
载有黏菌素和银纳米粒子的冻干人羊膜的安全性考虑。
Appl Biochem Biotechnol. 2024 Mar;196(3):1419-1434. doi: 10.1007/s12010-023-04618-3. Epub 2023 Jul 7.
4
Voriconazole-impregnated multilayered AMT and intracorneal plus intracameral injection in recalcitrant fungal corneal ulcer.伏立康唑浸渍多层 AMT 联合角膜内及前房内注射治疗难治性真菌性角膜溃疡。
BMJ Case Rep. 2022 Mar 29;15(3):e246659. doi: 10.1136/bcr-2021-246659.
5
Efficacy of rhNGF-loaded amniotic membrane transplantation for rabbit corneal epithelial and nerve regeneration.负载rhNGF的羊膜移植对兔角膜上皮和神经再生的疗效
Int J Ophthalmol. 2021 Nov 18;14(11):1653-1659. doi: 10.18240/ijo.2021.11.02. eCollection 2021.
Mycoses. 2018 Dec;61(12):916-930. doi: 10.1111/myc.12822. Epub 2018 Jul 27.
4
Medicated ocular bandages and corneal health: potential excipients and active pharmaceutical ingredients.眼用药物绷带和角膜健康:潜在辅料和活性药物成分。
Pharm Dev Technol. 2018 Mar;23(3):255-260. doi: 10.1080/10837450.2017.1377232. Epub 2017 Sep 21.
5
In Vitro Evaluation of the Drug Reservoir Function of Human Amniotic Membrane Using Moxifloxacin as a Model Drug.
Cornea. 2017 May;36(5):594-599. doi: 10.1097/ICO.0000000000001168.
6
Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting-a review.眼科中的羊膜:特性、制备、储存及移植适应证——综述
Cell Tissue Bank. 2017 Jun;18(2):193-204. doi: 10.1007/s10561-017-9618-5. Epub 2017 Mar 2.
7
Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops.1%伏立康唑滴眼液吸收与清除的开放标签研究。
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6896-6898. doi: 10.1128/AAC.00683-16. Print 2016 Nov.
8
Fungal Keratitis in North India: Spectrum of Agents, Risk Factors and Treatment.印度北部的真菌性角膜炎:病原体谱、危险因素及治疗
Mycopathologia. 2016 Dec;181(11-12):843-850. doi: 10.1007/s11046-016-0042-3. Epub 2016 Jul 29.
9
Evaluation of Intracameral Amphotericin B in the Management of Fungal Keratitis: Randomized Controlled Trial.前房内注射两性霉素B治疗真菌性角膜炎的评估:随机对照试验
Ocul Immunol Inflamm. 2016 Oct;24(5):493-7. doi: 10.3109/09273948.2015.1057597. Epub 2015 Sep 23.
10
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.在一项随机试验中对局部用1%伏立康唑和5%那他霉素治疗真菌性角膜炎的重新评估。
Br J Ophthalmol. 2015 Sep;99(9):1190-5. doi: 10.1136/bjophthalmol-2014-306485. Epub 2015 Mar 4.